On Dec. 31, 2012, the U.S. Food and Drug Administration (FDA) approved Sirturo (bedaquiline) as part of combination therapy to treat adults with multi-drug resistant pulmonary tuberculosis (TB) when other alternatives are not available. Read more.

FDA approves drug to treat multi-drug resistant TB

FDA approves first anti-diarrheal drug for HIV/AIDS patients

HHS releases modifications to HIPAA privacy, security, enforcement, and breach notification rule

Joint Commission proposes alarm management as 2014 National Patient Safety Goal

Study: Mindfulness meditation may help patients with chronic inflammation

Study: Donor feces more effective than vancomycin in treatment of recurrent C. difficile

Study: NP-staffed clinic improves care, lowers cost for women with benign breast conditions

‘Post-hospital syndrome’ in NEJM

Study: Disinfecting caps reduce CLABSI rates

NEJM article addresses challenges of evaluating patient satisfaction

Creating a Magnet® culture using the ANA Code of Ethics

How one hospital helps staff nurses pay for advanced academic degrees

Building collaboration between CNOs and direct-care nurses

Highlights from the 2012 ANCC National Magnet Conference®

Too young to be a nurse leader?

Caring for older lesbian, gay, bisexual, and transgender adults

How to love and care for yourself unconditionally

Find the best route to your career destination

The healing didn’t stop during Sandy

Charge Nurse University: Preparing future nurse leaders

Fending off disaster for a frostbite victim

Health, safety, & wellness

Issues up close

Headlines from the Hill

Ensuring quality and saving time

Stemming the rising tide of acute kidney injury

Uncover your inner nurse athlete

The healthy nurse

Helping patients survive sepsis

January 2013 e-Edition

Cooling The Hot Flashes

Treat The Menopause – Don’t Ignore It

Social Security “reform:” Throwing Grandma under the bus

Yes, Every Woman’s Menopause Experience Is Different

The fiscal cliff: Who should pay America’s debt?

Nursing’s Future